Form 4: Adicet Bio Director Michael Grissinger Acquires 70,200 Stock Options
SEC Form 4 Filing
Director Michael Grissinger acquired 70,200 stock options in Adicet Bio, Inc. on April 17, 2025, according to a Form 4 filing with the SEC.
Summary
- Michael Grissinger, a director of Adicet Bio, Inc., acquired 70,200 stock options on April 17, 2025.
- The exercise price of these options is $0.5258.
- The options vest in 36 equal monthly installments starting April 17, 2025, contingent upon continued service as a director.
- The options expire on April 16, 2035.
- Following the transaction, Grissinger directly owns 70,200 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment. This is a routine disclosure of stock option grants to a director, which is a common practice. It doesn't inherently indicate positive or negative sentiment.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule implies a three-year commitment from the director.
Industry Context
This is a standard SEC Form 4 filing, reflecting a common practice of granting stock options to directors as part of their compensation package. This aligns with industry norms for incentivizing board members.
Comparison to Industry Standards
- Stock option grants to directors are a common practice in the biotechnology industry to align their interests with those of shareholders.
- The vesting schedule of 36 months is also typical for such grants.
- The specific number of options and exercise price would depend on the company's size, stage of development, and overall compensation strategy.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 04/17/2025 | Date of earliest transaction and grant date of stock options. |
| 04/17/2025 | Vesting start date for the stock options. |
| 04/16/2035 | Expiration date of the stock options. |
| 04/21/2025 | Date of signature on the Form 4 filing. |
Keywords
Adicet Bio, Grissinger, stock options, Form 4, director, acquisition, beneficial ownership, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.